Company Profile of Fujian South Pharmaceutical Co., Ltd.

Fujian South Pharmaceutical Co., Ltd. (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. FSP is strong in R&D, with a pathbreaking team in Shanghai R&D Center. We hold 6 PCT patents and 33 China patents for processing of taxanes, tabines and tinibs. FSP endeavors to become a well-known oncology pharmaceutical company in the world in next decade.